Global Health Matters
Talking to CNBC-TV18's Parikshit Luthra (4 June 2021), IFPMA Director General Thomas Cueni shared his perspective on global vaccine supplies. Main interview highlights from Thomas Cueni: We from IFPMA called out to governments across the world to join us in a five-step plan to urgently address vaccine equity. The first ...
Read More
This oped has been originally published on The Telegraph on 3rd June 2021. Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) In 2016, the United States National Security Council[1]drew up a playbook on fighting pandemics so ...
Read More
This oped was originally published on Foresight Global Health on 3rd June 2021. Innovations in diabetes treatment and management have made enormous contributions to global health over the past 100 years, but there are still obstacles that must be overcome to slow the growth of the disease and reduce its ...
Read More
This blog was originally published on Media Planet Clinical Trials Campaign on 20 May 2021. “The biopharmaceutical industry and regulatory authorities have been working to ensure clinical trials have been progressing in all diseases throughout the global pandemic. When the COVID-19 pandemic began, most of our focus went to ‘how ...
Read More
This oped was originally published on International Business Times on 11 April 2021. Imagine if China had refused to share Covid-19's genetic sequences with other countries. Vaccine development would have been delayed indefinitely. Monitoring the virus would have been next to impossible. Thankfully, that didn't happen. Chinese scientists shared the ...
Read More
This oped was published on the Financial Times on 25 April 2021 1998, 39 pharmaceutical companies sued Nelson Mandela’s South African government to stop legislation that allowed pharmacists to substitute generic HIV/Aids drugs for brand-name ones. It was one of the dumbest things the industry ever did. What started as ...
Read More
On the first anniversary of the Access to COVID-19 Tools Accelerator (ACT Accelerator), high-level representatives – from pharma and biotech trade associations and vaccine manufacturers from both developed and developing countries – met to discuss the challenges of scaling-up vaccine production and ensuring vaccine equity. Present at the meeting were ...
Read More
On April 12 and 13 the African Union and the African CDC organized Africa’s Vaccine Manufacturing for Health Security virtual conference, opened by HE Moussa Faki Mahamat, Chairperson of the African Union Commission and chaired by HE Félix Antoine Tshilombo Tshisekedi, Chair of the African Union and President of the ...
Read More
I am honored to have been invited to speak on behalf of the innovative pharmaceutical industry at the launch of the new Global Diabetes Compact on 14 April 2021. The Global Diabetes Compact is being launched at an important time in history of diabetes. 100 years ago, the discovery of ...
Read More
On 9 April 2021, I participated in very lively debate hosted by Intelligence Squared, and moderated by John Donvan, Putlizer Prize Finalist and America's best recognized moderator of live event debate and four-time Emmy Award winner. I agreed to disagree with Brook Baker, Professor of Law, Northeastern University School of ...
Read More
Increasing manufacturing capacity for COVID-19 vaccines is one of the biggest challenges we need to address in our common goal to bring this pandemic to an end. Science has delivered not one but several vaccines that are safe and effective and the goal is ensure fair and equitable delivery to ...
Read More
2020 witnessed a decade of scientific progress compressed into just 12 months. And as a result we now have, ahead of all predictions, a number of C-19 vaccines that can protect the heroic healthcare workers, the elderly and the vulnerable; and hopefully society as a whole as long as we ...
Read More
This blog was originally published on Media Planet Infectious Disease campaign on 24 March 2021. Whilst we are still in the midst of COVID-19, the worst pandemic since 1918 which is affecting every part of our lives, we can draw some lessons that will allow us to be better prepared ...
Read More
A summit was convened in a matter of weeks by Chatham House, in collaboration with COVAX, IFPMA, DCVMN, and BIO, took place on 8-9 March 2021. A discussion document helped inform participants, gave an overview of the current COVID-19 vaccine manufacturing supply chain and identified emerging challenges. While the meeting was conducted under Chatham ...
Read More
Antibiotics have transformed healthcare. But today, the ubiquitous use of these live-saving drugs has led to the development of antibiotic-resistant bacteria. Once-treatable diseases like common infections of the bloodstream, urinary or respiratory tracts are becoming more difficult to treat using these tools. Combating drug resistance means facing a silent pandemic ...
Read More